Entity
  • Cilcare

    Created in 2014
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    265 4,575
  • Activities

  • Technologies

  • Entity types

  • Location

    Rue du Professeur Joseph Anglada, 34090 Montpellier, France

    Montpellier

    France

  • Employees

    Scale: 11-50

    Estimated: 39

  • SIREN

    803146125
  • Engaged corporates

    41
    12 37
  • Added in Motherbase

    5 years, 6 months ago
Description
  • Value proposition

    MAKING HEARING A PRIORITY

    CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases.

    CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus.

    CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy.

    CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring.
    We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.



    hearing disorders, tinnitus, hearing loss, pharmaceutical development, pharmacology, clinical development, preclinical development, GLP ototoxicology, hearing loss, tinnitus, auditory safety, ear disorders, AI, and precision medicine

  • Original language

    MAKING HEARING A PRIORITY

    CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases.

    CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus.

    CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy.

    CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring.
    We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.

Corporate interactions BETA
Corporate TypeTweets Articles
Mouvement Impact France
Mouvement Impact France
Civic and Social Organizations
Mouvement Impact France
Civic and Social Organizations
Other

5 Oct 2024


Pfizer
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Other

5 Oct 2024


Servier Pharmaceuticals
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Other

5 Oct 2024


MEDEF
MEDEF
NGO, Think Tank, Civic and Social Organizations
MEDEF
NGO, Think Tank, Civic and Social Organizations
Other

15 Sep 2024


J.P. Morgan J.P. Morgan
Bank
Other

5 Mar 2024


Shionogi & Co., Ltd
Shionogi & Co., Ltd
Pharmaceutical
Shionogi & Co., Ltd
Pharmaceutical
Other

5 Oct 2024


The Exploration Company The Exploration Company
Other

14 Nov 2023


Moderna
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Other

25 Apr 2024


Takeda
Takeda
Pharmaceutical, Pharmaceutical Manufacturing
Takeda
Pharmaceutical, Pharmaceutical Manufacturing
Other

25 Apr 2024


AQUA-VALLEY
AQUA-VALLEY
Public business cluster, Non-profit Organizations
AQUA-VALLEY
Public business cluster, Non-profit Organizations
Other

19 Apr 2024


Similar entities
Loading...
Loading...
Social network dynamics